Stewart W F, Van Rooyen J B, Cundiff G W, Abrams P, Herzog A R, Corey R, Hunt T L, Wein A J
Department of Epidemiology, Johns Hopkins University, 615 North Wolfe Street, Room 6039E, Baltimore, MD 21205, USA.
World J Urol. 2003 May;20(6):327-36. doi: 10.1007/s00345-002-0301-4. Epub 2002 Nov 15.
the National Overactive BLadder Evaluation (NOBLE) Program was initiated to better understand the prevalence and burden of overactive bladder in a broad spectrum of the United States population.
to estimate the prevalence of overactive bladder with and without urge incontinence in the US, assess variation in prevalence by sex and other factors, and measure individual burden.
US national telephone survey using a clinically validated interview and a follow-up nested study comparing overactive bladder cases to sex- and age-matched controls.
noninstitutionalized US adult population.
a sample of 5,204 adults >/=18 years of age and representative of the US population by sex, age, and geographical region.
prevalence of overactive bladder with and without urge incontinence and risk factors for overactive bladder in the US. In the nested case-control study, SF-36, CES-D, and MOS sleep scores were used to assess impact.
the overall prevalence of overactive bladder was similar between men (16.0%) and women (16.9%), but sex-specific prevalence differed substantially by severity of symptoms. In women, prevalence of urge incontinence increased with age from 2.0% to 19% with a marked increase after 44 years of age, and in men, increased with age from 0.3% to 8.9% with a marked increase after 64 years of age. Across all age groups, overactive bladder without urge incontinence was more common in men than in women. Overactive bladder with and without urge incontinence was associated with clinically and significantly lower SF-36 quality-of-life scores, higher CES-D depression scores, and poorer quality of sleep than matched controls.
the NOBLE studies do not support the commonly held notion that women are considerably more likely than men to have urgency-related bladder control problems. The overall prevalence of overactive bladder does not differ by sex; however, the severity and nature of symptom expression does differ. Sex-specific anatomic differences may increase the probability that overactive bladder is expressed as urge incontinence among women compared with men. Nonetheless, overactive bladder, with and without incontinence, has a clinically significant impact on quality-of-life, quality-of-sleep, and mental health, in both men and women.
启动了美国膀胱过度活动症评估(NOBLE)项目,以更好地了解美国广大人群中膀胱过度活动症的患病率和负担。
估计美国有和没有急迫性尿失禁的膀胱过度活动症的患病率,评估患病率在性别和其他因素上的差异,并衡量个体负担。
采用经过临床验证的访谈进行美国全国电话调查,并进行一项后续嵌套研究,将膀胱过度活动症病例与性别和年龄匹配的对照组进行比较。
美国非机构化成年人群。
5204名年龄大于或等于18岁的成年人样本,按性别、年龄和地理区域代表美国人群。
美国有和没有急迫性尿失禁的膀胱过度活动症的患病率以及膀胱过度活动症的危险因素。在嵌套病例对照研究中,使用SF-36、CES-D和MOS睡眠评分来评估影响。
膀胱过度活动症的总体患病率在男性(16.0%)和女性(16.9%)之间相似,但按症状严重程度划分的特定性别患病率差异很大。在女性中,急迫性尿失禁的患病率随年龄从2.0%增至19%,在44岁后显著增加;在男性中,随年龄从0.3%增至8.9%,在64岁后显著增加。在所有年龄组中,没有急迫性尿失禁的膀胱过度活动症在男性中比在女性中更常见。有和没有急迫性尿失禁的膀胱过度活动症与临床显著更低的SF-36生活质量评分、更高的CES-D抑郁评分以及比匹配对照组更差的睡眠质量相关。
NOBLE研究不支持普遍认为的女性比男性更易出现与急迫性相关的膀胱控制问题这一观点。膀胱过度活动症的总体患病率不存在性别差异;然而,症状表现的严重程度和性质确实存在差异。特定性别的解剖学差异可能使膀胱过度活动症在女性中比在男性中更易表现为急迫性尿失禁。尽管如此,有和没有尿失禁的膀胱过度活动症对男性和女性的生活质量、睡眠质量和心理健康都有临床显著影响。